Obesity and dyslipidemia: a review of current evidence
J Vekic, A Stefanovic, A Zeljkovic - Current Obesity Reports, 2023 - Springer
Abstract Purpose of Review Obesity is accompanied by atherogenic dyslipidemia, a specific
lipid disorder characterized by both quantitative and qualitative changes of plasma …
lipid disorder characterized by both quantitative and qualitative changes of plasma …
White adipocyte dysfunction and obesity-associated pathologies in humans
CE Hagberg, KL Spalding - Nature Reviews Molecular Cell Biology, 2024 - nature.com
The prevalence of obesity and associated chronic diseases continues to increase
worldwide, negatively impacting on societies and economies. Whereas the association …
worldwide, negatively impacting on societies and economies. Whereas the association …
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry
D Tomasoni, C Vitale, F Guidetti… - European Journal of …, 2024 - Wiley Online Library
Aims The aim of this analysis was to provide data on the overall comorbidity burden, both
cardiovascular (CV) and non‐CV, in a large real‐world heart failure (HF) population across …
cardiovascular (CV) and non‐CV, in a large real‐world heart failure (HF) population across …
Molecular mechanisms of western diet-induced obesity and obesity-related carcinogenesis—A narrative review
D Lathigara, D Kaushal, RB Wilson - Metabolites, 2023 - mdpi.com
The present study aims to provide a narrative review of the molecular mechanisms of
Western diet-induced obesity and obesity-related carcinogenesis. A literature search of the …
Western diet-induced obesity and obesity-related carcinogenesis. A literature search of the …
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Overweight and obesity are characterized by excessive fat mass accumulation produced
when energy intake exceeds energy expenditure. One plausible way to control energy …
when energy intake exceeds energy expenditure. One plausible way to control energy …
Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical …
The 21st century is characterized by an increasing incidence and prevalence of obesity and
the burden of its associated comorbidities, especially cardiometabolic diseases, which are …
the burden of its associated comorbidities, especially cardiometabolic diseases, which are …
Western diets and chronic diseases
TE Adolph, H Tilg - Nature Medicine, 2024 - nature.com
Abstract 'Westernization', which incorporates industrial, cultural and dietary trends, has
paralleled the rise of noncommunicable diseases across the globe. Today, the Western-style …
paralleled the rise of noncommunicable diseases across the globe. Today, the Western-style …
Synthesis of β-acids loaded chitosan-sodium tripolyphosphate nanoparticle towards controlled release, antibacterial and anticancer activity
B Tian, X Qiao, S Guo, A Li, Y Xu, J Cao… - International Journal of …, 2024 - Elsevier
The development of nanoparticles loaded with natural active ingredients is one of the hot
trends in the pharmaceutical industry. Herein, chitosan was selected as the base material …
trends in the pharmaceutical industry. Herein, chitosan was selected as the base material …
Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype
A Di Sessa, AP Passaro, AM Colasante… - International Journal of …, 2023 - nature.com
Background Obesity and kidney damage have been closely linked in adults, but little is still
known in childhood. Objective To identify predictors of kidney damage in children with …
known in childhood. Objective To identify predictors of kidney damage in children with …
Efficacy and safety of glucagon-like peptide-1 receptor agonists on body weight and cardiometabolic parameters in individuals with obesity and without diabetes: a …
HUH Ansari, SU Qazi, F Sajid, Z Altaf, S Ghazanfar… - Endocrine Practice, 2024 - Elsevier
Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially for type 2
diabetes mellitus, show promise in promoting weight loss and improving heart health in …
diabetes mellitus, show promise in promoting weight loss and improving heart health in …